Steven O'Day - Jan 2, 2022 Form 4 Insider Report for AGENUS INC (AGEN)

Role
Chief Medical Officer
Signature
By: /s/ Steven J. O'Day
Stock symbol
AGEN
Transactions as of
Jan 2, 2022
Transactions value $
$0
Form type
4
Date filed
1/4/2022, 05:43 PM
Next filing
Jan 6, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGEN Stock Option (Right to Buy) Award $0 +150K $0.00 150K Jan 2, 2022 Common Stock 150K $3.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third of the stock options vest on the one-year anniversary of the date of grant, with the remainder vesting in equal quarterly installments thereafter; provided that the Reporting Person maintains a service relationship with the Issuer through each such vesting date.